⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
prnewswire.com
JNJ
GILD
BMY
REGN
ABBV
ADPT
Global Medical Tourism Market to Reach USD 58 Billion by 2032, Due to Shift Toward Affordable, Quality Healthcare Abroad | DelveInsight
globenewswire.com
TEL
AMWL
SI
CSCO
PHG
IBM
MDT
AMD
JNJ
ISRG
ZBH
BSX
GMED
PG
EL
ABBV
HON
SN
ENOV
CON
BOSC
CL
UL
LE
ON
ALF
SOC
USAR
APO
TRMK
ZIM
CNMD
OFLX
PARA
OR
$73 Billion Non-Opioid Therapeutics Industry Assessment, 2032 Featuring AbbVie, GlaxoSmithKline, Acorda Therapeutics, Allay Therapeutics, Alnylam Pharmaceuticals and Other Key Players
globenewswire.com
ABBV
GSK
ALNY
DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing
globenewswire.com
ABBV
Global Medical Device Contract Manufacturing Market is Predicted to Cross the USD 190 Billion Mark by 2032, Owing to the Rising Demand for Advanced Healthcare Solutions | DelveInsight
globenewswire.com
TMO
PFE
AMGN
BMY
MRK
DHR
ABBV
GOOG
MSFT
JNJ
MDT
BSX
SYK
EW
ISRG
EMR
BIOX
EXAS
QRVO
TER
ADI
TXN
ON
INTC
NVDA
AMD
HPQ
DELL
IBM
GE
FISV
ADP
PAYX
NOW
CRM
ORCL
SAP
ADSK
CDNS
SNPS
AMAT
INFY
HPE
LOGI
ATHM
BIIB
GILD
REGN
VRTX
AMRN
AZN
LLY
NVS
CRSP
EDIT
NTLA
ALNY
INCY
XRAY
COO
MASI
IRTC
MRNA
EMB
ADMA
ICUI
HOLX
LH
DGX
RDNT
EVTC
AFYA
CHKP
DDOG
SMCI
ALGN
THRY
PTC
MCHP
NXPI
QCOM
SWKS
MU
WDC
STX
Medincell Publishes its Consolidated Half-Year Financial Results
businesswire.com
TEVA
ABBV
Say Hello To CaterAi, The First AI Agent That Expertly Plans Catering For Any Event In Under 5 Minutes
globenewswire.com
ABBV
NVDA
Medical Aesthetic Devices Market Projected to Reach $37.9 Billion by 2029
globenewswire.com
JNJ
BHC
ABBV
Genmab Announces New Data from Phase 1b/2 EPCORE ® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
businesswire.com
GMAB
ABBV
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AMGN
PFE
LLY
AZN
BMY
NVS
SNY
GSK
UCB
ARQT
REGN
INCY
ABBV
BIIB
MRK
JNJ
VNDA
RAPT
CHAI
ONON
ION
ASMB
CRVS
APG
KSCP
KYMR
XBI
IBB
ADSK
CDNS
SNPS